Forbes @Forbes
If data from the 2 to 5 age group trials is promising, the company says it will proceed with regulatory filings to seek approval from the FDA https://t.co/4Wr9RpNa0F — PolitiTweet.org
Created
Fri Jan 14 04:32:03 +0000 2022
Likes
33
Retweets
6
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely Available
Forbes @Forbes
If data from the 2 to 5 age group trials is promising, the company says it will proceed with regulatory filings to seek approval from the FDA https://t.co/4Wr9RpNa0F — PolitiTweet.org